Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1551 to 1600 of 2529

TitleReference numberPublishedLast updated
Ustekinumab for treating moderate to severe plaque psoriasisTA180
Care of dying adults in the last days of lifeQS144
Intrapartum careQS105
Molecular testing strategies for Lynch syndrome in people with colorectal cancerHTG430
Migalastat for treating Fabry diseaseHST4
Drug misuse prevention: targeted interventionsNG64
Everolimus for advanced renal cell carcinoma after previous treatmentTA432
Apremilast for treating active psoriatic arthritisTA433
Lateral interbody fusion in the lumbar spine for low back painHTG431
Trabecular stent bypass microsurgery for open-angle glaucomaHTG432
Healthcare-associated infections: prevention and control in primary and community careCG139
Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromideES5
U-Drain for people needing night drainage of urine or dialysis fluidMIB95
Smart One for measuring lung functionMIB96
MenopauseQS143
HumiGard for preventing inadvertent perioperative hypothermiaHTG428
Osteoporosis: assessing the risk of fragility fractureCG146
eazyplex SuperBug kits for detecting carbapenemase-producing organismsMIB94
Stable anginaQS21
Cerebral palsy in under 25s: assessment and managementNG62
Antimicrobial stewardship: changing risk-related behaviours in the general populationNG63
Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutationTA429
Sofosbuvir–velpatasvir for treating chronic hepatitis CTA430
Boston Keratoprosthesis Type I for corneal blindnessMIB91
CentriMag for heart failureMIB92
Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysisMIB93
Refractory extrapulmonary sarcoidosis: infliximabES4
Smartinhaler for asthmaMIB90
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomibTA427
TuberculosisQS141
Learning disability: identifying and managing mental health problemsQS142
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donationCG135
Everolimus with exemestane for treating advanced breast cancer after endocrine therapyTA421
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA422
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimensTA423
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancerTA424
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemiaTA425
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemiaTA426
Extracorporeal shockwave therapy for Achilles tendinopathyHTG426
Radiation therapy for early Dupuytren's diseaseHTG427
Pulmonary sarcoidosis: infliximabES2
Blood transfusionQS138
Oral health promotion in the communityQS139
Hypothermia: prevention and management in adults having surgeryCG65
Ticagrelor for preventing atherothrombotic events after myocardial infarctionTA420
Epiduroscopic lumbar discectomy through the sacral hiatus for sciaticaHTG425
XprESS multi sinus dilation system for treating chronic sinusitisHTG424
CORTRAK 2 Enteral Access System for placing nasoenteral feeding tubesMIB48
Mental wellbeing and independence for older peopleQS137
Transition between inpatient hospital settings and community or care home settings for adults with social care needsQS136

Results per page

  1. 10
  2. 25
  3. 50
  4. All